Nano-X Imaging (NNOX) Non-Current Debt (2021 - 2025)

Nano-X Imaging's (NNOX) quarterly Non-Current Debt came in at $173000.0 in Q4 2025, down 94.88% on a QoQ basis from $3.4 million in Q4 2023.

Nano-X Imaging (NNOX) Non-Current Debt (2021 - 2025) Analysis & Trends

Nano-X Imaging (NNOX) has 4 years of Non-Current Debt data on file, last reported at $173000.0 in Q4 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $173000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $173000.0 (changed N/A YoY) and the FY2025 annual result came in at $173000.0, changed N/A from the prior year.
Non-Current Debt fell to $173000.0 in Q4 2025, from $3.4 million in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $3.7 billion in Q1 2022 to a low of $173000.0 in Q4 2025.
A 4-year average of $973.1 million and a median of $3.5 million in 2022 frame the typical range for Non-Current Debt.
Annual changes were most pronounced in 2022 — Non-Current Debt soared 91505.26% — and 2023, when it tumbled 99.91%.
Tracing NNOX's Non-Current Debt over 4 years: stood at $3.8 million in 2021, then retreated by 8.3% to $3.5 million in 2022, then fell by 2.96% to $3.4 million in 2023, then sank by 94.88% to $173000.0 in 2025.
The last three Non-Current Debt figures came in at $173000.0 (Q4 2025), $3.4 million (Q4 2023), and $3.3 million (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	29.60 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.19 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	7.34 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.65 Bn
10	Nano-X Imaging	61,578.01	-44.16 Mn	-2.59 Mn	-

Download Data